Related references
Note: Only part of the references are listed.The C Allele of ATM rs11212617 Associates With Higher Pathological Complete Remission Rate in Breast Cancer Patients Treated With Neoadjuvant Metformin
Elisabet Cuyas et al.
FRONTIERS IN ONCOLOGY (2019)
The Effects of Metformin and Weight Loss on Biomarkers Associated With Breast Cancer Outcomes
Ruth E. Patterson et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Novel Insights Into the Impact of Lifestyle-Based Weight Loss and Metformin on Obesity-Associated Biomarkers in Breast Cancer
Ana Elisa Lohmann et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
The Effects of Metformin and Weight Loss on Biomarkers Associated With Breast Cancer Outcomes
Ruth E. Patterson et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Novel Insights Into the Impact of Lifestyle-Based Weight Loss and Metformin on Obesity-Associated Biomarkers in Breast Cancer
Ana Elisa Lohmann et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Estrogen Metabolism in Abdominal Subcutaneous and Visceral Adipose Tissue in Postmenopausal Women
Natalia Hetemaki et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Changes in insulin receptor signaling underlie neoadjuvant metformin administration in breast cancer: a prospective window of opportunity neoadjuvant study
Ryan J. O. Dowling et al.
BREAST CANCER RESEARCH (2015)
Sex hormones and breast cancer risk and prognosis
Elizabeth Folkerd et al.
BREAST (2013)
Metformin Decreases Circulating Androgen and Estrogen Levels in Nondiabetic Women With Breast Cancer
Carlo Campagnoli et al.
CLINICAL BREAST CANCER (2013)
Metformin in early breast cancer: a prospective window of opportunity neoadjuvant study
Saroj Niraula et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Effect of Different Doses of Metformin on Serum Testosterone and Insulin in Non-Diabetic Women With Breast Cancer: A Randomized Study
Carlo Campagnoli et al.
CLINICAL BREAST CANCER (2012)
Endogenous Sex Hormone Changes in Postmenopausal Women in the Diabetes Prevention Program
Catherine Kim et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes
Kaixin Zhou et al.
NATURE GENETICS (2011)
Promoter-specific effects of metformin on aromatase transcript expression
Nirukshi U. Samarajeewa et al.
STEROIDS (2011)
Metformin inhibits aromatase expression in human breast adipose stromal cells via stimulation of AMP-activated protein kinase
Kristy A. Brown et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Reproductive steroid hormones and recurrence-free survival in women with a history of breast cancer
Cheryl L. Rock et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells
Ryan J. O. Dowling et al.
CANCER RESEARCH (2007)
Fabricating data: How substituting values for nondetects can ruin results, and what can be done about it
Dennis R. Helsel
CHEMOSPHERE (2006)
Postmenopausal levels of oestrogen, androgen, and SHBG and breast cancer: long-term results of a prospective study
A Zeleniuch-Jacquotte et al.
BRITISH JOURNAL OF CANCER (2004)
Share Paper
